Clinical trial · Observational
Preliminary Study on Eye Features of Patients With Malignant Tumors
Application of White Eye Imaging Health Care System on Diagnosis of Malignant Tumors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Based on the theory of traditional Chinese Medicine, this study collects eye features of white eyes through the White Eye Imaging Health Care System under visible light and establishes a database of eye-eye features corresponding to the disease. The computer image analysis and artificial intelligence technology are used to visualize the eye. The features were extracted and classified, and the corresponding changes in the characteristics of the traditional Chinese medicine and the disease were analyzed statistically to establish an analytical model corresponding to the disease.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Patients | — | UNRESOLVED | — |
| Feature Elongation | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Model of white-eye ocular features in patients with malignant tumors
- timeFrame
- 2.5 years
- description
- The test will use Artificial Intelligence technology to analyze and learn the features of white-eye eyes of healthy people and patients with malignant tumors, and establish a model of eye characteristics of malignant tumors.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria:
* Malignant tumor patients with clear pathological diagnosis;
* Those who have no serious primary diseases of the cardiovascular, cerebrovascular, respiratory, endocrine, urinary, blood and other systems;
* The main organs (hematopoiesis, heart, lung, liver, and kidney) have no obvious abnormal function; ④Age ≥18 years old, ≤75 years old; ⑤ No serious eye disease;
* The patient volunteered to participate in this study.
Exclusion Criteria:
* Patients with severe blood loss (because when the bleeding exceeds 300ml, the white eye color of the patient is often pale white);
* Poor patient compliance; ③ pregnant and lactating women;
* Can't cooperate with inspection properly; ⑤ Cannot read or understand the scale.References
Publications (0)
Data not yet available